Bicara Therapeutics Inc. (BCAX) Reports Material Event to SEC

Bicara Therapeutics Inc. (NASDAQ:BCAX) filed a Form 8-K with the Securities and Exchange Commission on February 19, 2026, disclosing a material event.

Bicara Therapeutics Inc.'s stock currently trades at $15.42 with a market capitalization of $1.0B. The Healthcare company's stock moved following the disclosure.